Repligen Corporation (RGEN)

Nasdaq: RGEN · Biological Products, (No Diagnostic Substances) · Waltham, MA · filing with the SEC since 1995

Grade5.4

◀ Past 6.3● Present 6.4▶ Future 4.1

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 26, 2026	Mar 14, 2025	Feb 22, 2024	Feb 22, 2023	Feb 17, 2022	Feb 24, 2021	Feb 26, 2020	Mar 1, 2019	Feb 22, 2018	Feb 23, 2017
Revenue	738,256	634,439	632,362^r	801,536	670,534	366,260	270,245	194,032	141,236	104,541
Cost of revenue	352,011	359,794	353,922	345,830	279,280	156,634	119,099	86,531	67,050	47,117
Research and development	54,177	43,200	42,722	43,936	34,274	20,182	19,450	15,821	8,672	7,355
Selling, general and administrative	290,508	263,368	218,584^r	215,829	183,866	119,621	95,613	65,692	51,509	30,853
Total costs and expenses	683,089	669,553	584,659^r	576,866	503,285	296,437	234,162	168,044	127,231	88,567
Operating income	55,167	-35,114	47,703^r	224,670	167,249	69,823	36,083	25,988	14,005	15,974
Interest expense	21,513	20,731	2,503	1,162	11,278	10,768^r	9,292	6,709	6,441	3,768
Interest and investment income	27,574	35,827	24,135	6,978	176	1,741	5,324	1,895	371	346
Other income (expense), net	2,815	-5,174	8,123	-9,531	-1,168^r	-214	-314	262	-687	-860
Total non-operating income (expense)	7,216	8,079	9,004^r	-5,530	-13,706	-10,606	-9,932	-4,552	-6,757	-4,282
Income before income taxes	62,383	-27,035	56,707^r	219,140	153,543	59,217	26,151	21,436	7,248	11,692
Income tax expense	13,489	-1,521	21,111^r	33,181	25,252	-709	4,740	4,819	-21,105	11
Net income	48,894	-25,514	35,596^r	185,959	128,291	59,926	21,411	16,617	28,353	11,681
Earnings per share, basic	0.87	-0.46	0.64^r	3.35	2.33	1.14	0.44	0.38	0.74	0.35
Earnings per share, diluted	0.86	-0.46	0.63^r	3.24	2.24	1.11	0.44	0.37	0.72	0.34
Weighted average shares, basic	56,234	55,937	55,720	55,460	55,015^r	52,554^r	48,343,000	43,767,000^r	38,234,000^r	33,573^r
Weighted average shares, diluted	56,561,000^b	55,937,000^b	56,377,000^b	57,455,000^b	57,264,000^rb	53,892,000^rb	49,206,000	45,471,000^r	39,150,000^r	34,099,000^rb

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton RGEN · research, not advice